278 related articles for article (PubMed ID: 25462232)
1. Studies on indolizines. Evaluation of their biological properties as microtubule-interacting agents and as melanoma targeting compounds.
Ghinet A; Abuhaie CM; Gautret P; Rigo B; Dubois J; Farce A; Belei D; Bîcu E
Eur J Med Chem; 2015 Jan; 89():115-27. PubMed ID: 25462232
[TBL] [Abstract][Full Text] [Related]
2. Discovery of indolizines containing triazine moiety as new leads for the development of antitumoral agents targeting mitotic events.
Lucescu L; Ghinet A; Belei D; Rigo B; Dubois J; Bîcu E
Bioorg Med Chem Lett; 2015 Sep; 25(18):3975-9. PubMed ID: 26227778
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic substituted indolizines as new colchicine site tubulin polymerisation inhibitors.
Sardaru MC; Craciun AM; Al Matarneh CM; Sandu IA; Amarandi RM; Popovici L; Ciobanu CI; Peptanariu D; Pinteala M; Mangalagiu II; Danac R
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1581-1595. PubMed ID: 32752898
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of fluoro analogues of antimitotic phenstatin.
Ghinet A; Tourteau A; Rigo B; Stocker V; Leman M; Farce A; Dubois J; Gautret P
Bioorg Med Chem; 2013 Jun; 21(11):2932-40. PubMed ID: 23618708
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
6. Indolizine-phenothiazine hybrids as the first dual inhibitors of tubulin polymerization and farnesyltransferase with synergistic antitumor activity.
Moise IM; Bîcu E; Farce A; Dubois J; Ghinet A
Bioorg Chem; 2020 Oct; 103():104184. PubMed ID: 32891861
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization and biological evaluation of anti-cancer indolizine derivatives via inhibiting β-catenin activity and activating p53.
Moon SH; Jung Y; Kim SH; Kim I
Bioorg Med Chem Lett; 2016 Jan; 26(1):110-3. PubMed ID: 26608553
[TBL] [Abstract][Full Text] [Related]
8. Biological evaluation of indolizine-chalcone hybrids as new anticancer agents.
Park S; Kim EH; Kim J; Kim SH; Kim I
Eur J Med Chem; 2018 Jan; 144():435-443. PubMed ID: 29288944
[TBL] [Abstract][Full Text] [Related]
9. New indolizines with phenanthroline skeleton: Synthesis, structure, antimycobacterial and anticancer evaluation.
Danac R; Al Matarneh CM; Shova S; Daniloaia T; Balan M; Mangalagiu II
Bioorg Med Chem; 2015 May; 23(10):2318-27. PubMed ID: 25882524
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro cytotoxicity evaluation of novel naphthindolizinedione derivatives.
Defant A; Guella G; Mancini I
Arch Pharm (Weinheim); 2007 Mar; 340(3):147-53. PubMed ID: 17315260
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and anticancer activity of analogues of phenstatin, with a phenothiazine A-ring, as a new class of microtubule-targeting agents.
Abuhaie CM; Bîcu E; Rigo B; Gautret P; Belei D; Farce A; Dubois J; Ghinet A
Bioorg Med Chem Lett; 2013 Jan; 23(1):147-52. PubMed ID: 23200248
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antiproliferative activity of indolizine derivatives incorporating a cyclopropylcarbonyl group against Hep-G2 cancer cell line.
Shen YM; Lv PC; Chen W; Liu PG; Zhang MZ; Zhu HL
Eur J Med Chem; 2010 Jul; 45(7):3184-90. PubMed ID: 20304535
[TBL] [Abstract][Full Text] [Related]
13. 3-Amino-thieno[2,3-b]pyridines as microtubule-destabilising agents: Molecular modelling and biological evaluation in the sea urchin embryo and human cancer cells.
Eurtivong C; Semenov V; Semenova M; Konyushkin L; Atamanenko O; Reynisson J; Kiselyov A
Bioorg Med Chem; 2017 Jan; 25(2):658-664. PubMed ID: 27956038
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of phenanthroindolizidine alkaloids and evaluation of their antitumor activities and toxicities.
Ikeda T; Yaegashi T; Matsuzaki T; Yamazaki R; Hashimoto S; Sawada S
Bioorg Med Chem Lett; 2011 Oct; 21(19):5978-81. PubMed ID: 21865039
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of heteroaromatic 6,7-diaryl-2,3,8,8a-tetrahydroindolizin-5(1H)-ones for cytotoxicity against the HCT-116 colon cancer cell line.
Kimball FS; Himes RH; Georg GI
Bioorg Med Chem Lett; 2008 Jun; 18(11):3248-50. PubMed ID: 18479919
[TBL] [Abstract][Full Text] [Related]
16. Anticancer activity of novel pyrido[2,3-b]indolizine derivatives: the relevance of phenolic substituents.
Boot A; Brito A; VAN Wezel T; Morreau H; Costa M; Proença F
Anticancer Res; 2014 Apr; 34(4):1673-7. PubMed ID: 24692696
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of B-ring analogues of (-)-rhazinilam.
Décor A; Monse B; Martin MT; Chiaroni A; Thoret S; Guénard D; Guéritte F; Baudoin O
Bioorg Med Chem; 2006 Apr; 14(7):2314-32. PubMed ID: 16314101
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, topoisomerase-targeting activity and growth inhibition of lycobetaine analogs.
Baechler SA; Fehr M; Habermeyer M; Hofmann A; Merz KH; Fiebig HH; Marko D; Eisenbrand G
Bioorg Med Chem; 2013 Feb; 21(3):814-23. PubMed ID: 23266176
[TBL] [Abstract][Full Text] [Related]
19. New imidazo[2,1-b]thiazole derivatives: synthesis, in vitro anticancer evaluation, and in silico studies.
Park JH; El-Gamal MI; Lee YS; Oh CH
Eur J Med Chem; 2011 Dec; 46(12):5769-77. PubMed ID: 22033063
[TBL] [Abstract][Full Text] [Related]
20. Novel 6,7-diphenyl-2,3,8,8a-tetrahydro-1H-indolizin-5-one analogues as cytotoxic agents.
Sharma VM; Adi Seshu KV; Vamsee Krishna C; Prasanna P; Chandra Sekhar V; Venkateswarlu A; Rajagopal S; Ajaykumar R; Deevi DS; Rao Mamidi NV; Rajagopalan R
Bioorg Med Chem Lett; 2003 May; 13(10):1679-82. PubMed ID: 12729640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
